More on RNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:RNTX)
Delayed: 0.76 -0.02 (2.56%)
Prev. Close $0.78  
Open$0.78 
52 Wk High$ 
52 Wk Low$ 
Day High$0.78 
Day Low$0.73 
P/E N/A  
EPS$ 
Volume243,351 

Friends, Peers and Foes (?): ENTA WVE (more...)

Jul 21, 2026 04:11 PM Form 8-K Rein Therapeutics, Inc. For: Jul 20
Jul 21, 2026 08:01 AM Rein Therapeutics expands Phase 2 IPF trial to all five countries
Jul 21, 2026 08:00 AM Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries
Jul 20, 2026 07:33 AM Maxim Group Starts Rein Therapeutics (RNTX) at Buy
Jul 14, 2026 07:23 PM Form SCHEDULE 13G/A Rein Therapeutics, Inc. Filed by: Voss Capital, LP
Jun 11, 2026 08:02 AM Rein Therapeutics expands Phase 2 trial to UK, enrolls 16 patients
Jun 11, 2026 08:01 AM Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom
Jun 8, 2026 09:18 AM Form DEFA14A Rein Therapeutics, Inc.
Jun 8, 2026 09:18 AM Form ARS Rein Therapeutics, Inc. For: Dec 31
Jun 8, 2026 09:18 AM Form DEF 14A Rein Therapeutics, Inc. For: Jul 20
View All Articles

Entities mentioned with RNTX

View All Entities